Intracellular autocrine VEGF signaling promotes EBDC cell proliferation, which can be inhibited by Apatinib-Reference-Cited by-同舟云学术

Intracellular autocrine VEGF signaling promotes EBDC cell proliferation, which can be inhibited by Apatinib

Published:2016-04 Issue:2 Volume:373 Page:193-202
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Peng Sui,Zhang Yanyan,Peng Hong,Ke Zunfu,Xu Lixia,Su Tianhong,Tsung Allan,Tohme Samer,Huang Hai,Zhang Qiuyang,Lencioni Riccardo,Zeng Zhirong,Peng Baogang,Chen Minhu,Kuang Ming

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. Diagnosis and management of cholangiocarcinoma;Sandhu;Curr. Gastroenterol. Rep,2008

2. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States;Welzel;J. Natl Cancer Inst,2006

3. Autocrine VEGF signaling promotes proliferation of neoplastic Barrett's epithelial cells through a PLC-dependent pathway;Zhang;Gastroenterology,2014

4. Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer;Xia;J. Urol,2006

5. Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer;Chatterjee;J. Clin. Invest,2013

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modified Hongyu Decoction promotes wound healing by activating the VEGF/PI3K/Akt signaling pathway;Acta Biochimica Polonica;2023-12-05

2. Novel VEGFR-2 inhibitors as antiangiogenic and apoptotic agents via paracrine and autocrine cascades: Design, synthesis, and biological evaluation;Bioorganic Chemistry;2023-10

3. Expression of p53 as a biomarker in determining response to apatinib for advanced gastric cancer;Frontiers in Oncology;2023-08-15

4. Efficacy of apatinib combined with temozolomide in the treatment of recurrent high‑grade glioma: A meta‑analysis;Experimental and Therapeutic Medicine;2023-08-03

5. Efficacy and Safety of Apatinib in Patients with Recurrent Glioblastoma;Drugs in R&D;2023-07-19